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Abstract  40 
Obesity is associated with complications during pregnancy and increased health risks in 
the newborn. The objective of this study was to establish possible relationships between 
gut microbiota, body weight, weight gain, and biochemical parameters in pregnant 
woman. Fifty pregnant women were classified according to their body mass index (BMI) 
in normal weight (n=34) and overweight (n=16) groups. Gut microbiota composition 45 
was analyzed by quantitative real-time PCR in faeces and biochemical parameters in 
plasma at 24 weeks of pregnancy. Reduced numbers of Bifidobacterium and Bacteroides 
and increased numbers of Staphylococcus, Enterobacteriaceae and E. coli were detected 
in overweight compared to normal weight pregnant women. E. coli numbers were higher 
in women with excessive weight gain than in woman with normal weight gain during 50 
pregnancy, while Bifidobacterium and Akkermansia muciniphila showed an opposite 
trend. In the whole population, increased total bacteria and Staphylococcus numbers 
were related to increased plasma cholesterol levels. Increased Bacteroides numbers were 
related to increased HDL cholesterol and folic acid levels, and reduced triglyceride 
levels. Increased Bifidobacterium numbers were related to increased folic acid levels. 55 
Increased Enterobacteriaceae and E. coli numbers were related to increased ferritin and 
reduced transferrin, while Bifidobacterium levels showed the opposite trend. Therefore, 
gut microbiota composition is related to body weight, weight-gain and metabolic 
biomarkers during pregnancy, which might be of relevance to the management of 
woman and infant’s health.  60 
Key words: pregnancy, gut microbiota, obesity, cholesterol, triglycerides, folic acid, 
ferritin. 
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Introduction 
The prevalence of obesity is rapidly increasing worldwide, constituting an important 
health issue. Obesity is the result of a positive imbalance between energy intake and 65 
energy expenditure over a long period and is related to the development of other 
disorders such as diabetes, dyslipemia and cardiovascular diseases. Obesity is also 
associated with complications during pregnancy and at the delivery for women and with 
increased health risks in newborn (1-3).  
There are several genetic and environmental factors such as diet, cultural behaviour, and 70 
socioeconomic status, which influence obesity (4,5). In addition, recent reports suggest 
that the nature and composition of the intestinal microbiota are altered in obesity (6,7). 
Lean individuals have more Bacteroidetes, while obese individuals have more 
Firmicutes, including Clostridium clusters, in their intestinal microbiota (6,7). It has been 
proposed that such bacterial composition improved the ability of the host to extract 75 
energy from the diet and to store this energy in the adipose tissue (7). Gut microbiota has 
also been related to body weight and body weigh loss under a lifestyle intervention in 
humans (8,9). Although obesity is an important health issue during pregnancy, the 
relationships between the gut microbiota composition and obesity has been scarcely 
studied in pregnant women (10). 80 
The aim of the present study was to analyse the microbiota composition of pregnant 
women and establish its possible relationships with body weight, weight gain and 
biochemical parameters to progress in the understanding of the role of the microbiota in 
the health status of pregnant woman.   
 85 
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Experimental methods 
Study participants 
The pregnant women were recruited at 20 weeks of pregnancy at the Clinical University 
Hospital “San Cecilio” de Granada, Spain. Women were classified according to their 
pre-pregnancy Body Mass Index (BMI) into two groups, overweight women (n=16) with 90 
BMI>25 and normal weight women (n=34) with BMI<25 (Table 1). Signed informed 
consent was obtained from the studied women after a full explanation of the study was 
given by a member of the team at the first visit. Participants were assured of anonymity 
and confidentiality. After the visit at the first trimester, women were examined by the 
obstetrician again at 24 (2nd trimester) and 34 weeks (3rd trimester) and clinical 95 
parameters were recorded. At 24 weeks of pregnancy, faecal and blood samples were 
obtained for microbiological and biochemical analysis. Data on weight before pregnancy 
was used to calculate weight gain during pregnancy. Normal weight gain ranges were 
from 11.5 to 16.0 kg for normal weight women (BMI 19.8–25.0) and from 7.0 to 11.5 kg 
for overweight women (BMI >25), respectively, over pregnancy according to the 100 
Institute of Medicine (IOM) criteria (11). Total weight gains above these values, 16 kg 
for normal-weight women and 11.5 kg for overweight women, were considered 
excessive weight. Data on gestation time and birth weights of the newborns were also 
collected. This study was conducted according to the guidelines laid down in the 
Declaration of Helsinki and all procedures involving human subjects were approved by 105 
the ethics committee of the Hospital involved in the study. Written informed consent 
was obtained from all subjects before their inclusion in the study.  
 
Dietary assessment  
  5
Food diary records of pregnant women were kept for 72h (2 weekdays and 1 weekend 110 
day) at 24 weeks of pregnancy. Detailed information on how to record food and drink 
consumed using common household measures was provided. Food diary records were 
returned to their dietician, and analyzed for energy, water and nutrient contents based on 
the CESNID food-composition database of Spanish foods(12).    
 115 
Biochemical parameters  
Fasting plasma glucose, total cholesterol, HDL cholesterol, triglycerides, urea, 
creatinine, uric acid, bilirubin and iron were measured by enzyme-colorimetric 
automated methods for clinical chemistry (Modular analytics EVO, Roche, Neuilly sur 
Seine Cedex, France). LDL cholesterol was calculated using the Friedwald’s formula 120 
(13). Ferritin, transferrin, folate and thyroid - stimulating hormone (TSH) levels were 
measured by using the automatic analyser Elecsys 2010 with modular analytics E170 
(Roche, Neuilly sur Seine Cedex, France). The transferrin saturation index was 
calculated using the following formula: TSI (%) = (ferritin (ug/ml).100)/(transferrin 
(mg/dl)x1.24).  125 
  
Sample preparation and DNA extraction  
Faecal samples were frozen immediately at -20ºC and kept until processing. Faeces (1g) 
were diluted 1: 10 (w/v) in PBS (pH 7.2), homogenized and used for DNA extraction. 
DNA from pure cultures of reference bacterial strains and faecal samples were extracted 130 
using the QIAamp DNA stool Mini kit (Qiagen, Hilden, Germany) following the 
manufacturer’s instructions. The concentration of DNA was determined with a 
Nanodrop-1000 spectrophotometer (Nanodrop, Wilmington, DE). 
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Analysis of faecal microbiota composition 135 
Quantitative real time PCR (qPCR) was used to characterize the microbiota by using of 
specific primers targeting different bacterial groups and the SYBR® Green PCR Master 
Mix (SuperArray Bioscience Corporation, Frederick, MD, USA), as previously 
described (9,10). PCR amplification and detection were performed with an ABI PRISM 
7000-PCR sequence detection system (Applied Biosystems, Warrington, UK). Bacterial 140 
concentration from each sample was calculated by comparing the Ct values obtained 
from standard curves. Standard curves were created using serial 10-fold dilution of pure 
culture DNA corresponding to 102 to 109 cell equivalents/ml (genome equivalents/ml). 
Conversion of the amount of bacteria DNA in samples determined by qPCR to 
theoretical genome equivalents required the assumption that the genome size and 16S 145 
rRNA gene copy number for each bacterial group analyzed was similar. The following 
genome sizes were used in the study: 2.3 Mb for Bifidobacterium (using B. longum as 
standard), 2.9 Mb for Lactobacillus (L. casei), 5.2 Mb for Bacteroides (B. fragilis), 4 Mb 
for C. coccoides group, 3.3 Mb for C. leptum group, 4.6 Mb for Enterobacteriaceae and 
E. coli, 2.8 Mb for Staphylococcus (St. aureus) and 2.7 Mb for Akkermansia 150 
muciniphila. Genome sizes were obtained from NCBI data base (Genome project). 
Standard curves were created using the following reference strains: Bifidobacterium 
longum subsp. longum CECT 4503, Bacteroides fragilis DSMZ 2451; Clostridium 
coccoides DSMZ 933; C. leptum DSMZ 935; Staphylococcus aureus CECT 86; 
Lactobacillus casei ATCC 393; E. coli CECT 45 and Akkermansia muciniphila strain 155 
MucT (ATCC BAA-835T). 
 
Statistical analyses 
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Statistical analyses were done using the SPSS 11.0 software (SPSS Inc, Chicago, IL, 
USA). Data distribution was analysed by applying the Kolmogorov-Smirnov test and 160 
creating a Gaussian. Due to non-normal distribution, microbial data are expressed as 
medians with interquartile ranges (IQR). The Mann-Whitney U-test was applied for 
comparisons between bacterial numbers of normal and overweight women and between 
women with excessive and normal weight gain over pregnancy. Differences in 
prevalence of bacterial groups were established by applying the Chi-square test. 165 
Correlations between variables were determined by applying the Spearman’s rank 
correlation. A P <.050 was considered statistically significant for all tests. 
 
RESULTS 
Body weight, body mass index, and weight gain over pregnancy   170 
Clinical characteristics of the studied women at recruitment time were similar in both 
groups (Table 1) except for BMI and body weight. The body weight of the overweight 
women was significantly higher than that of normal weight women during pregnancy, 
although no significantly differences (P= .120) in weight gain were detected between the 
groups over time. BMI was significantly different (P <.050) between normal weight and 175 
overweight women and increased in both groups over pregnancy.  The infants were born 
at term and the infant’s birth weight of the overweight women were higher than those of 
normal weight women (P= .028).  
 
Dietary intakes 180 
Dietary data of normal weight and overweigh pregnant women at 24 weeks of pregnancy 
are shown in Table 2. No significant differences in dietary intake of energy, 
macronutrients or on food group level were found between both groups of women. Only 
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the intake of fiber was slightly higher (P= .057) in normal weight than in overweight 
woman. When women were grouped according to the total weight gain over pregnancy 185 
into two groups (excessive and normal weight gain), no significant differences in dietary 
intake of energy, macronutrients or on food group level were found between the two 
groups. No correlations were found between dietary intakes, body weight and body 
weight gain.  
 190 
Biochemical parameters  
Biochemical parameters of pregnant women at 24 weeks subdivided according to their 
BMI in normal and overweight women are shown in Table 3. Bilirubin, iron and folic 
acid levels were significantly higher in normal than in overweight women (P=.021, P= 
.021 and P= .042, respectively). HDL cholesterol was higher (P= .050) in normal than in 195 
overweight women, whereas total cholesterol and triglycerides levels were significantly 
higher in overweight than in normal weight women (P= .019 and P= .034, respectively). 
Moreover, increased levels of triglycerides (R=0.30, P =.033) and total cholesterol 
(R=0.43, P =.002) and reduced levels of bilirubin (R=-0.36, P = .019) and iron (R=-
0.33, P = .019) correlated to overweight women.   200 
When women were grouped according to the total weight gain over pregnancy into two 
groups (excessive and normal weight gain), correlations with some biochemical 
parameters were also detected. Increased levels of total cholesterol (R=0.33, P = .020) 
and ferritin (R=0.45, P = .001) correlated with women with excessive weight gain over 
pregnancy.  205 
 
Microbiota composition in normal and overweight women 
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The bacterial numbers detected in faecal samples of normal- and overweight women are 
shown in Table 4. Bifidobacterium and Bacteroides numbers were significantly higher 
(P > .001 and P = .035, respectively) in normal weight women than in overweight 210 
women, whereas Enterobacteriaceae (P = .001), E. coli (P = .005) and Staphylococcus 
(P = .006) numbers were lower in normal weight than in overweight women. C. 
coccoides group numbers were slightly higher in overweight women than in normal 
weight woman, but not significantly (P = .088).  
The ratio of Bifidobacterium to C. coccoides group was significantly higher (P < .001) 215 
in normal weight than in overweight women. The ratio of Bifidobacterium to both 
Clostridium groups (C. coccoides plus C. leptum) was also significantly higher (P < 
.001) in normal weight than in overweight women.  
Increased numbers of Bifidobacterium (R=- 0.56, P < .001) and Bacteroides (R= -0.34, 
P = .020) correlated to normal weight women, while a different trend was found for 220 
Staphylococcus (R=0.67, P = .003), Enterobacteriaceae (R=0.46, P < .001) and E. coli 
(R=0.40, P = .004) (Fig 1). An increased ratio of Bifidobacterium to C. coccoides 
correlated to lower BMI (R=-0.60, P < .001). Similarly, an increased Bifidobacterium to 
C. coccoides plus C. leptum ratio was positively related to normal weight women (R=-
0.54, P < .001).  225 
Microbiota composition according to weight gain over pregnancy  
Faecal microbiota composition of woman showing normal or excessive weight gain over 
pregnancy is shown in Table 5. E. coli numbers were significantly higher (P= .045) in 
women with excessive weight gain than in women with normal weight gain over 
pregnancy. A similar trend was found for Enterobacteriaceae numbers although the 230 
differences were not significant (P = .142). Contrary to this tendency, Akkermansia 
muciniphila and Bifidobacterium numbers were higher (P = .020 and P = .078, 
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respectively) in women with normal weight gain than in those with excessive weight 
gain.  
The prevalence of C. leptum group and Staphylococcus was higher in women with 235 
excessive weight-gain than in women with normal weight gain over pregnancy (P = .545 
and P = .124). 
Increased numbers of Bifidobacterium (R=-0.31, P = .029), Bacteroides (R=-0.36, P= 
.019) and A. muciniphila (R= -0.34, P = .017) correlated significantly to normal weight 
gain over pregnancy (Fig 2). Opposite, increased numbers of Enterobacteriaceae 240 
(R=0.28, P = .050) and E. coli (R=0.42, P = .002) correlated with excessive weight gain 
over pregnancy (Fig. 2) 
 
Relationships between microbiota composition and dietary intakes 
In the whole women population, only increased numbers of total bacteria correlated to 245 
reduced energy (R= -0.71 P< .001), animal protein (R= -0.66, P= .001), cholesterol (R= 
-0.57, P= .007) and PUFA (R= -0.52 P< .015) intakes. The same trend was detected 
between total bacteria and energy (R=-0.78 P< .001 and R=-0.07 P= .002), animal 
protein (R= -0.61 P< .015 and R= -0.75 P= .001), and cholesterol (R= -0.52, P< .043 
and R=- 0.58 P= .018) intakes in the normal weight group and in the normal weight gain 250 
group.  
 
Relationships between microbiota composition and biochemical parameters 
In the whole women population, total bacterial positively correlated to cholesterol 
(R=0.350, P =.013, respectively). Increased numbers of Staphylococcus were related to 255 
increased levels of cholesterol (R=0.68, P = .003). Increased numbers of 
Enterobacteriaceae and E. coli counts were significantly correlated to increased levels 
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of ferritin (R=0.324, P= .023 and R=0.425, P = .002) and saturation transferrin index 
(R=0.302, P = .035 and R=0.439, P = .002) and reduced levels of transferrin (R=-0.353, 
P = .013 and R=-0.341, P= .017). In contrast, increased numbers of Bifidobacterium 260 
were related to reduced levels of ferritin (R=-0.420, P = .003) and saturation transferrin 
index (R=-0.388, P= .006) and to increased levels of transferrin (R=0.348, P= .014). In 
addition, increased numbers of Bifidobacterium were related to increased levels of folic 
acid (R=0.308, P= .032). Increased numbers of Bacteroides were related to increased 
levels of HDL cholesterol (R=0.518, P < .001) and folic acid (R=0.333, P = .020) and to 265 
reduced levels of triglycerides (R=-0.371, P = .009).  
In normal weight women, increased numbers of total bacteria correlated to increased 
levels of cholesterol (R=0.383, P=.025), while in overweight women the correlations 
were not significant.  
In normal weight gain women, increased levels of total bacteria were related to 270 
increased levels of total cholesterol (R=0.390, P = .019), HDL cholesterol (R=0.335, P = 
.046) and folic acid (R=0.338, P = .044). Increased numbers of Staphylococcus 
correlated with increased levels of total cholesterol (R=0.881, P < .001). Moreover, 
increased numbers of Bacteroides correlated with higher levels of HDL cholesterol 
(R=0.620, P = .002). In women with excessive weight gain over pregnancy, increased 275 
numbers of Bifidobacterium were related to increased levels of HDL cholesterol 
(R=0.572, P = .042) and reduced levels of total triglycerides (R=-0.682, P = .010). 
Increased Bacteroides numbers were related to reduced levels of triglycerides (R=-
0.809, P = .001).  
 280 
Relationships between maternal microbiota composition and infant’s birth weight 
  12
In the whole women population, significant positive correlations were found between E. 
coli (R=0.331, P = .039) and C. coccoides (R=0.323, P = .045) numbers and infant’s 
birth weight were found. In overweight women, positive correlation were also found 
between E. coli numbers and infant’s birth weight (R=0.673, P = .035).  In excessive 285 
weight gain women, significant negative correlations were found between numbers of 
Lactobacillus group and infant’s birth weight (R=-0.917, P = .001).   
 
Discussion 
This study reports differences in the intestinal microbiota of normal weight and 290 
overweight pregnant women, associated with body weight and weight gain over 
pregnancy, suggesting that the intestinal microbiota is a relevant target to weight 
management in pregnancy. Moreover, newborns form overweight pregnant woman had 
higher birth weight than those from normal weight pregnant women, suggesting the 
transference of the mother’s features to their newborns. In this context, the results can 295 
also be of relevance to the transference of the aberrant microbiota to the newborns, 
which use the mother’s microbiota as inoculums for microbiota development (14). In this 
context, a positive relationship between the maternal intestinal E. coli numbers and 
infant’s birth weight was demonstrated, which could be related to infant’s body weight 
regulation. In contrast, in excessive weight gain women increased Lactobacillus 300 
numbers were related to reduced infant’s birth weight, suggesting a positive role of this 
bacterial group in infant’s body weight regulation.  
In the present study, increased numbers of Bacteroides, which belong to Bacteroidetes 
phylum, were detected in normal weight compared to overweight women. In previous 
studies, the faecal microbiota of lean human subjects was characterized by having 305 
increased numbers of Bacteroidetes compared to that of obese subjects. Moreover, 
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weight loss under dietary intervention was associated with increases in Bacteroidetes 
and Bacteroides fragilis group numbers in adults and adolescents (6,8,9). Therefore, the 
association of Bacteroidetes with a lean phenotype established in previous studies has 
also been confirmed in pregnant woman included in this study. Nevertheless, 310 
Bacteroides numbers were significantly higher in overweight than in normal weight 
women and associated with excessive weight gain over pregnancy in the only previous 
study carried out in pregnant women(10). These results contradict all previous findings on 
the role of Bacteroides in obesity and highlight the importance of the new evidence 
provided by this study in this regard. 315 
Increased numbers of Bifidobacterium were also related to normal weight women 
compared to overweight women, and a similar trend was detected in women with normal 
weight gain compared to those with excessive weight gain over pregnancy.  This is in 
agreement with recent studies, which showed that levels of Bifidobacterium were 
reduced in infants who developed overweight at 7 years old, compared to normal weight 320 
children(14); however, this association was not established in the previous study 
conducted in pregnant women(10). In animal models, a role has also been attributed to 
Bifidobacterium in obesity. Obese Zucker rats (fa/fa) and mice fed a high fat diet 
showed reduced Bifidobacterium counts (15, 16). Moreover, the administration of 
prebiotics to mice fed a high fat diet increased the intestinal Bifidobacterium numbers, 325 
which positively correlated with improved glucose tolerance and glucose-induced 
insulin secretion and with the normalization of the inflammatory tone (16).  
In addition, the ratio of Bifidobacterium to either C. coccoides or to C. coccoides plus C. 
leptum group numbers was also significantly higher in normal weight than in overweight 
women, suggesting a negative role of Clostridium in obesity. In agreement, obese human 330 
subjects were shown to have increased numbers of Firmicutes in their faecal microbiota 
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as compared to lean subjects (6). Moreover, weight loss under dietary intervention has 
also been associated with reduction in Firmicutes or C. coccoides and C. histolyticum 
group proportions (6, 8, 9). Altogether, these results confirm that increases in the relative 
abundance of members of Firmicutes and, in particular, of some Clostridium clusters is 335 
associated with excessive body weight.   
Staphylococcus numbers were also increased in overweight compared to normal weight 
women in agreement with a previous study conducted in pregnant woman (10). Moreover, 
children becoming overweight at 7 years old showed a greater number of 
Staphylococcus aureus in faeces during infancy (14). In addition, Enterobacteriaceae and 340 
E. coli were significantly higher in overweight than in normal weight women and also in 
women with excessive weight gain over pregnancy. Increased levels of Gram-negative 
bacteria, which could include Enterobacteriaceae and E. coli, could be related to the 
endotoxaemia and inflammatory tone associated with obesity as evidenced in animal 
models (16).   345 
Total cholesterol and triglycerides levels were significantly higher in overweight than in 
normal weight women and increased cholesterol levels correlated with excessive weight 
gain over pregnancy, as expected. In addition, folic acid was significantly lower in 
overweight than in normal weight women, which is a nutrient involved in the correct 
differentiation of the neural tube during foetal organogenesis. In fact, obesity is a risk 350 
factor for neural tube defects (17). Moreover, iron levels were also lower in overweight 
than in normal weight women and increased levels of ferritin correlated to higher weight 
gain in the whole population and in the excessive weight gain group. It has been 
described a relationship between obesity and iron deficiency, which can be reflected in 
reduced plasma levels of iron and transferrin and increased plasma levels of ferritin and 355 
saturation transferrin index (18, 19, 21, 22). The iron deficiency associated with obesity has a 
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multifactorial aetiology and could be due to impairment of intestinal iron uptake and 
iron release from stores, and to inadequate iron bioavailability because of inflammation. 
In particular, abnormal ferritin concentrations have been explained by the chronic low-
grade inflammation associated with obesity, metabolic syndrome and gestational and 360 
type 2 diabetes (20, 21, 22). Increases in serum ferritin concentrations early in gestation also 
constitute a risk of gestational diabetes, partly mediated by the maternal fat mass and 
obesity (22).  
This study also reports interesting relationships between biochemical parameters and 
specific intestinal bacterial groups in pregnant women. While Bacteroides numbers 365 
seemed to have a positive effect on plasma biomarkers of lipid metabolism, 
Staphylococcus numbers seemed to have a negative effect particularly on plasma 
cholesterol. Cholesterol and other sterols have been shown to stimulate the growth of at 
least S. aureus(23); however, in this study no correlation was found between cholesterol 
intake and Staphylococcus numbers, which could explain a link with plasma cholesterol 370 
levels. Other mechanisms have been proposed to justify the influence of the intestinal 
microbiota on lipid metabolism, including generation of different short-chain fatty acids 
and regulation of the host gene expression (6, 7, 24, 25) but the specific relationships found 
in the present study remain to be elucidated.  
Bifidobacterium numbers were positively related to plasma folic acid levels in the whole 375 
population, which may be due to the ability of some strains of this genus to synthesise 
and secrete folates in the human intestinal environment, providing a complementary 
endogenous source of this vitamin (26). This metabolic trait of Bifidobacterium strains 
could contribute to improving the nutritional status of the pregnant woman and the 
foetus.  380 
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Enterobacteriaceae/E. coli and Bifidobacterium showed inverse relationships with 
transferrin, saturation transferrin index and ferritin, as well as with body weight in the 
whole population. Increases in serum transferrin saturation index, because of a 
transferrin decrease and ferritin increase, have been associated with a decrease of 
antibacterial activity of serum against enterobacteria, such as Salmonella enterica, which 385 
could contribute to favouring the survival of this bacterial group (27). In fact, infections 
are one of the conditions that can depress transferrin levels. The possibility that the 
overgrowth of Enterobacteriaceae in the gut environment might favour their 
translocation to some extent and cause a similar effect could not be disregarded. By 
contrast, the administration of inulin to pigs led to increased Lactobacillus and 390 
Bifidobacterium numbers and to up-regulating the expression of genes encoding for iron 
transporters in the enterocytes, which suggest a connexion between these bacterial 
groups and/or the prebiotic, and improved iron absorption (28). Therefore, the relative 
abundance of Bifidobacterium and Enterobacteriaceae may differently influence iron 
metabolism and, in turn, exert opposite effects on the nutritional status of pregnant 395 
woman. Unlikely the present study, a previous report on pregnant woman microbiota did 
not provide any data on biochemical parameters and their possible associations with the 
microbiota(10). 
In summary, specific bacterial groups are oppositely related to overweight and weight 
gain during pregnancy, pointing for a beneficial role of Bacteroides and Bifidobacterium 400 
in body weight regulation. In addition, novel associations between these bacterial groups 
and beneficial changes in metabolic biomarkers are provided, suggesting a connexion 
between the gut microbiota and the host metabolism. Altogether, these findings open 
new possibilities for the management of body weight and of the nutritional status of 
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pregnant women through modulation of the intestinal microbiota, which may have 405 
consequences on later infant’s health and deserve further investigations. 
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FIGURE LEGENDS 
 
Figure 1. Relations between numbers of faecal bacterial groups and weight. Data 520 
represent the positive samples. The line in the box is the median (50% percentile), with 
the lower line the lower 25% border (25% percentile) and the upper line the 75% (75% 
percentile) border. The end of the upper vertical line is the maximum data value, outliers 
not considered. The end of the lower vertical line is the lowest value, outliers not 
considered. The separate dots or asterisks indicate outliers. Lines showed the Spearman 525 
correlation (linear adjustment). 
 
Figure 2. Relations between numbers of faecal bacterial groups and weight gain over 
pregnancy. Data represent the positive samples. The line in the box is the median (50% 
percentile), with the lower line the lower 25% border (25% percentile) and the upper line 530 
the 75% (75% percentile) border. The end of the upper vertical line is the maximum data 
value, outliers not considered. The end of the lower vertical line is the lowest value, 
outliers not considered. The separate dots or asterisks indicate outliers. Lines showed the 
Spearman correlation (linear adjustment). 
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Table 1. Clinical characteristics of the studied subjects 
Women 
Characteristics1 Normal weight  
(n=34) 
Overweight 
(n=16) 
*P value 
Women    
Age (years) 31.0 (27.7-34.2) 29.0 (28.0-33.5) .646 
Height (cm) prior pregnancy 163.0 (158.0-167.0) 162.0 (158.0-166.0) .967 
Weight (kg)    
prior pregnancy 58.0 (53.2-64.5) 73.0 (70.0-84.0) > .001 
 1st trimester 62.5 (58.1-66.2) 75.4 (71.4-86.4) > .001 
 2nd trimester (24 wk) 66.4 (60.7-72.3) 77.3 (73.5-88.6) > .001 
 3rd trimester (34 wk) 70.4 (66.0-75.5) 81.2 (78.0-100.0) > .001 
Weight (kg) gain over pregnancy 11.7 (8.8-14.3) 10.0 (6.2-11.4) .120 
Body mass index (BMI)     
prior pregnancy 23.0 (20.8-24.3) 28.7 (26.3-31.2) > .001 
 1st trimester 23.3 (21.0-25.0) 29.0 (27.8-32.7) > .001 
 2nd trimester (24 wk) 24.0 (22.7-25.7) 30.0 (26.8-33.2) > .001 
 3rd trimester (34 wk) 26.6 (25.1-28.2) 30.8 (28.9-35.5) > .001 
Newborns    
Duration of gestation (weeks) 39.0 (38.5-40.0) 39.5 (39.0-41.0) .165 
Birth weight (kg) 3.20 (3.1-3.4) 3.50 (3.2-4.0) .028 
 
1Data are presented as medians (interquartile range).  
*Significant differences were calculated using Mann-Whitney U-test at P < .050.  
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Table 2. Daily energy and nutrient intake in normal and overweight women at 24 weeks of pregnancy. 
  Normal weight group (18<BMI<25) (n=34)   Overweight group (BMI>25) (n=16) 
  Median IQR   Median IQR 
Mann-Whitney  
U-test 
P-value 
Energy (kJ)   8.86 7.85 – 10.16   8.06 6.68 – 9.74 0.430 
Water (g)   8.40 6.47 – 11.17   8.02 7.27 – 12.31 1.000 
Protein (g)   82.14 73.0 - 99.0   86.54 75.0 - 103.0 0.610 
Protein (%)   16.31 14.7 - 17 7   17.53 15.2 - 20.1 0.265 
Plant protein (g)   25.04 22.7 - 28. 7   23.22 16.4 - 26.5 0.265 
Plant protein (%)   4.73 4.4 - 7.2   4.90 3.5 - 5.1 0.458 
Animal protein (g)   56.85 48.3 - 71.7   61.25 50.6 - 74.8 0.546 
Animal protein (%)  11.77 9.9 - 12.7   13.15 10.3 - 15.7 0.063 
Fat (g)   91.35 75.4 - 105.0   85.00 62.5 - 105.0 0.458 
Energy from fat (%)  40.28 35.8 - 44.7   40.31 33.5 - 44.3 0.926 
Saturated fat (g)   30.36 27.1 - 40.4   26.71 20.1 - 42.0 0.577 
Energy from saturated fat (%)  13.77 12.2 - 14.9   13.33 10.0 - 17.6 0.963 
MUFA (g)   37.20 30.0 - 48.5   34.34 27.4 - 41.0 0.577 
Energy from MUFA (%)   16.23 14.0 - 20.0   16.00 15.1 - 17.7 0.889 
PUFA (g)   13.88 11.2 - 16.4   12.00 9.2 - 16.7 0.458 
Energy from PUFA (%)   5.6 4.8 - 7.3   5.56 4.4 - 6.5 0.642 
Cholesterol (mg)   279.70 228.5 - 414.8   352.46 222.1 - 478.5 0.458 
CH (g)   227.70 200 - 262.0   197.00 171.8 - 262.7 0.330 
Energy from CH (%)   43.06 38.0 - 48.3   42.43 38.0 - 45.1 0.610 
Simple CH (g)   125.20 111.8 - 153.3   102.12 79.0 - 139.5 0.150 
Energy from simple CH (%)   22.02 19.5 - 27.0   21.23 18.6 - 23.2 0.280 
Complex CH (g)   101.51 87.5 - 110.8   98.00 74.8 - 120.2 0.889 
Energy from complex CH (%)  18.60 17.0 - 24.1   20.45 17.0 - 23.4 0.816 
Dietary fiber (g)  19.81 16.2 - 24.3    16.75 13.6 - 19.0 0.057 
Abbreviations:  PUFA = Polyunsaturated fatty acids, MUFA = Monounsaturated fatty acids, CH = Carbohydrates 
*Statistical significant differences were calculated by using the Mann-Whitney U test and established at P <0.050 
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Table 3. Biochemical parameters recorded at 24 weeks of pregnancy of normal and overweight women. 
Values at 24 weeks of pregnancy 
Biochemical parameter Units Reference values BMI<25 (n=34) a  BMI>25(n=16) a  
Mann- Whitney Test 
*P value 
Glucose  mg/dl 65-110 76.5 (69.7-81.0) 77.0 (63.5-90.0) .840 
Urea mg/dl 10-50 20.0 (17.5-25.6) 19.7 (14.7-22.7) .288 
Creatinine mg/dl 0.5-1.2 0.6 (0.5-0.7)  0.5 (0.5-0.6) .072 
Uric acid mg/dl 2.4-7.0 3.1 (2.7-3.7) 3.3 (2.9-3.7) .493 
Bilirubin  mg/dl 0-1 0.2 (0.2-0.3) 0.1 (0.1-0.3) .021 
Cholesterol mg/dl 120-220 233.0 (206.7-256.0) 259.0 (230.0-281.0) .019 
Triglycerides mg/dl 50-170 148.0 (119.0-186.0)  192.0 (163.0-225.0) .034 
HDL cholesterol mg/dl 45-65 77.0 (69.7-95.5)  66.0 (58.0-83.0) .050 
LDL cholesterol mg/dl 50-150 135.0 (99.7-150.0) 130.0 (99.0-138.0) .580 
Total protein g/dl 6.5-8.7 7.0 (6.6-7.1) 7.0 (6.7-7.1) .502 
Albumin g/dl 3.5-5.0 4.0 (3.7-4.1) 3.8 (3.6-4.0) .395 
Iron g/dl 45-150 79.5 (63.7-105.7)  60.0 (53.0-95.0) .021 
Ferritin ng/ml 30-400 19.0 (10.5-31.2)  20.0 (16.3-33.7) .356 
Transferrin mg/dl 212-360 358.5 (320.7-413.0) 350.0 (305.0-397.0) .288 
Saturation transferrin index % 17.1-30.6 18.7 (14.0-25.0) 16.5 (11.6-23.0) .362 
Folic acid ng/ml 3.1-17.5 15.3 (10.6-18.5)  10.5 (7.3-17.0) .042 
TSH µUI/ml 0.3-4.2 1.4 (0.9-1.7) 1.6 (1.0-1.6) .368 
a Data are shown as medians and interquartile range (IQR)  
* Statistical differences were calculated by using the Mann-Whitney U test.  Significantly difference was considered at P <.050. 
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Table 4. Bacterial numbers in faecal samples analyzed by qPCR at 24 weeks of pregnancy.  
 
Normal weight women (n=34) Overweight women (n=16) 
Microbial groups  
Pra Log genome equivalent/g b Pra Log genome equivalent/g b
Mann-Whitney test* 
P value  
Total cell counts  34/34 9.85 (9.40-10.24) 16/16 9.89 (9.40-10.02) .630 
Bifidobacterium  34/34 9.10 (8.53-9.52) 16/16 8.36 (7.74-8.57) >.001 
Lactobacillus group 34/34 7.48 (7.35-7.60) 16/16 7.70 (7.40-7.78) .053 
Clostridium coccoides group 34/34 8.52 (7.78-8.87) 16/16 8.75 (8.29-9.12) .088 
Clostridium leptum group 30/34 8.40 (8.04-8.78) 14/16 8.35 (7.37-8.66) .313 
Bacteroides   34/34 6.88 (6.21-7.23) 16/16 6.20 (6.00-6.66) .035 
Enterobacteriaceae 34/34 6.37 (6.10-6.76) 16/16 7.23 (6.65-7.90) .001 
E. coli  34/34 5.17 (4.68-5.70) 16/16 6.20 (5.50-7.14) .005 
Staphylococcus  8/34 4.40 (3.94-4.74) 9/16 5.78 (4.83-6.37) .006 
Akkermansia muciniphila 34/34 8.35 (7.56-9.00) 16/16 8.50 (7.10-9.45) .763 
a Prevalence (Pr) reflects the number of positive amplifications from total samples analysed by PCR (n=number of samples analysed) 
b Data are shown as medians and interquartile range (IQR) of cell equivalents (genome equivalent) per gram of faeces. 
* Statistical differences were calculated by using Mann-Whitney U test.  Significantly difference between groups was considered at P <.050. 
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Table 5. Bacterial numbers in faecal samples analyzed by qPCR according to recommend weight gain over pregnancy.   
Normal weight gain (n=36) Excessive weight gain (n=14) 
Microbial groups  
Pra Log genome equivalent/g b Pra Log genome equivalent/g b
Mann-Whitney test* 
P value  
Total cell counts  36/36 9.90 (9.51-10.25) 14/14 9.73 (9.18-10.00) .218 
Bifidobacterium  36/36 8.92 (8.27-9.44) 14/14 8.46 (8.13-8.22) .078 
Lactobacillus group 36/36 7.48 (7.39-7.64) 14/14 7.56 (7.35-7.76) .449 
Clostridium coccoides group 36/36 8.71 (8.07-8.97) 14/14 8.35 (8.15-8.67) .315 
Clostridium leptum group 32/36 8.42 (8.16-8.78) 12/14 8.17 (7.20-8.68) .268 
Bacteroides  36/36 6.42 (6.06-7.03) 14/14 6.64 (6.20-7.36) .331 
Enterobacteriaceae 36/36 6.55 (6.21-6.86) 14/14 6.84 (6.16-8.04) .142 
E. coli  36/36 5.26 (4.70-5.94) 14/14 6.25 (5.06-8.08) .045 
Staphylococcus  10/36 4.50 (4.33-5.74) 7/14 4.46 (4.08-5.62) .527 
Akkermansia muciniphila 36/36 8.54 (7.90-9.50) 14/14 8.12 (6.52-8.50) .020 
a Prevalence (Pr) reflects the number of positive amplifications from total samples analysed by PCR (n=number of samples analysed) 
b Data are shown as medians and interquartile range (IQR) of cell equivalents (genome equivalents) per gram of faeces. 
*Statistical differences were calculated by using Mann-Whitney U test.  Significantly difference between groups was considered at P < .050. 
Normal weight gains over pregnancy according to IOM were < 16.0 Kg (BMI<25) and < 11.5 Kg (BMI>25) 
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Figure 2.  
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